# AtaiBeckley share price (AtaiBeckley Inc., ATAI)

> AtaiBeckley Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. ATAI · Healthcare · Biotechnology · data as of 10 September 2026. Page: https://www.sectoralpha.in/us/stocks/atai

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $7.35 (+58.7% in a year)
- Revenue (Jun 2026): $1.7 M (+137.0% on a year ago)
- Profit (Jun 2026), incl. one-off: −$32.5 M (one-off item, see below)
- ROE: −297%, FY25

Biggest thing to watch: the price has already been rising for 12 weeks, so timing is the risk more than the business. ## What is the AtaiBeckley share price? AtaiBeckley Inc.'s share price was $7.35 at the close on 10 September 2026. It has been rising for 12 weeks. That is 55.7% above its average price over the last 200 trading days. In the last 52 weeks it traded between $3 and $7, and at that close it sat 99% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 13 weeks in a row. Over the last 5.2 years the share price moved −57% while the S&P 500 moved +79%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does AtaiBeckley pay? AtaiBeckley Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is AtaiBeckley on? AtaiBeckley is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is AtaiBeckley profitable? AtaiBeckley Inc. posted a net loss of $32.5 M in the Jun 2026 quarter. That quarter includes a one-off gain bigger than its revenue, so the comparison with last year does not reflect normal business. The full FY25 year was a loss of $660 M. That loss is 1,908.7% of the quarter's revenue. The same quarter a year earlier lost $27.7 M. 11 of the last 12 reported quarters were loss-making. Read this profit with care: at −$32.5 M it is bigger than the quarter's whole revenue of $1.7 M. No business earns more than it takes in from sales, so this is a one-off item (for example a debt settlement, a tax write-back or an asset sale), not money the business earned. The underlying business is running at a −2,590.4% operating margin. The jump on last year, and any P/E built on this profit, come from the one-off, not from a real turn in earnings. ## How much revenue does AtaiBeckley make, and is it growing? AtaiBeckley Inc. reported $1.7 M of revenue in the Jun 2026 quarter, +137.0% on the same quarter a year earlier. Over 4 years it has grown −33.1% a year on average. The last full year, FY25, came in at $4.1 M. The last four reported quarters add to $4.5 M. FY25 revenue was $4.1 M, +1,227.6% on the year before. Recent pace: the last four quarters grew +623.6% on average, against −33.1% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +93.7%, against +185.2% a year over the last 8 quarters (rolling over). ## How much of every $100 of sales does AtaiBeckley keep? AtaiBeckley Inc.'s sales have fallen to very little: FY25 revenue was $4.1 M, against $20.4 M in FY21. On sales that small an operating margin is not a useful reading, so this section is left out until sales recover. ## Is AtaiBeckley's profit turning into cash? AtaiBeckley Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 its operations used $103 M of cash, against −$660 M of profit. After $901 K of spending on assets, free cash was −$104 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does AtaiBeckley's cash go? AtaiBeckley Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $1.2 M on assets over the last 3 years. Averaged over those years that is 9.5% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $1.2 M over the last 3 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is AtaiBeckley's P/E ratio, and how does it compare with its own history? AtaiBeckley Inc. has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values AtaiBeckley Inc. at 666.6× its FY25 revenue of $4.1 M. The P/E comes back here once profit turns positive. ## Is the AtaiBeckley business getting better or worse? AtaiBeckley Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 11 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does AtaiBeckley earn on its capital? AtaiBeckley Inc. earned a ROE of −297% in FY25. Its return on capital used (ROIC) is left out: on sales this small it reads −393%, a number that says nothing useful about the business. ## Does AtaiBeckley have too much debt? AtaiBeckley Inc. has total debt of $4.3 M against shareholder equity of $176 M as of Jun 2026, so its debt is 0.02× its equity, which is very little. Year by year, that ratio went from 0.01 in FY21 to 0.02 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the AtaiBeckley shareholding pattern? 5.3% of AtaiBeckley Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 2.8 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is AtaiBeckley from balance-sheet trouble? For AtaiBeckley Inc., the Z-score is 0.60. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 0.60 is inside the danger zone, so the balance sheet is a real risk. ## How does AtaiBeckley rank in its industry? There is no score against its industry: AtaiBeckley Inc. is not among the largest members shown in this industry comparison for Biotechnology. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is AtaiBeckley compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to AtaiBeckley in size? AtaiBeckley is the 64th largest of 211 Biotechnology companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Zai Lab, Arcus Biosciences, Inc. and Beam Therapeutics Inc. Just below it: Xencor, Inc., NewAmsterdam Pharma Company N.V. and Recursion Pharmaceuticals, Inc. ### Biotechnology companies close in size

1. [Zai Lab Limited](https://www.sectoralpha.in/us/stocks/zlab) $2.8 billion
2. [Arcus Biosciences, Inc.](https://www.sectoralpha.in/us/stocks/rcus) $2.8 billion
3. [Beam Therapeutics Inc.](https://www.sectoralpha.in/us/stocks/beam) $2.8 billion
4. AtaiBeckley Inc. $2.7 billion
5. [Xencor, Inc.](https://www.sectoralpha.in/us/stocks/xncr) $2.6 billion
6. [NewAmsterdam Pharma Company N.V.](https://www.sectoralpha.in/us/stocks/nams) $2.5 billion
7. [Recursion Pharmaceuticals, Inc.](https://www.sectoralpha.in/us/stocks/rxrx) $2.4 billion

[All 211 Biotechnology companies, largest first](https://www.sectoralpha.in/us/sectors/biotechnology#all-companies)

### Companies close in size in other industries

1. [FB Financial Corporation](https://www.sectoralpha.in/us/stocks/fbk) $2.7 billion · Banks - Regional
2. [Stagwell Inc.](https://www.sectoralpha.in/us/stocks/stgw) $2.7 billion · Advertising Agencies
3. AtaiBeckley Inc. $2.7 billion
4. [Neogen Corporation](https://www.sectoralpha.in/us/stocks/neog) $2.7 billion · Medical Devices
5. [Patrick Industries, Inc.](https://www.sectoralpha.in/us/stocks/patk) $2.7 billion · Recreational Vehicles

## What else do people ask about AtaiBeckley? ### What were AtaiBeckley's latest quarterly results? AtaiBeckley Inc. reported revenue of $1.7 M and a net loss of $32.5 M for the Jun 2026 quarter. Earnings per share were −$0.09. The operating margin was −2,590.4%, 924.6 percentage points higher than a year earlier (as of 10 September 2026). ### What is AtaiBeckley's market cap? AtaiBeckley Inc.'s market capitalisation is $2.7 B at a stock price of $7.35. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 10 September 2026). ### How is AtaiBeckley performing? AtaiBeckley Inc.'s share price has been rising for 12 weeks. Over the past 13 weeks it has done better than the S&P 500, for 13 weeks running. This describes what the data did, not a rating (as of 10 September 2026). ### Will AtaiBeckley's stock price go up? This page does not forecast AtaiBeckley Inc.'s stock price. What it shows instead: the stock price is $7.35, and it has been rising for 12 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 10 September 2026). ### What could break the AtaiBeckley story? Biggest thing to watch: the price has already been rising for 12 weeks, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 10 September 2026). ### Is AtaiBeckley a stock worth studying right now? What the numbers show: AtaiBeckley Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 10 September 2026). This is research, not advice. We’re not SEBI-registered.